Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
21 studies found for:    Alzheimer's | Open Studies | United States, Utah
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial
Conditions: Mild Cognitive Impairment;   Dementia;   Alzheimer's Disease
Intervention:
2 Recruiting Implications for Management of PET Amyloid Classification Technology
Conditions: Mild Cognitive Impairment;   Dementia;   Alzheimer's Disease
Intervention: Drug: [18F]Flutemetamol
3 Recruiting A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)
Conditions: Healthy;   Alzheimer's Disease;   Mild Cognitive Impairment
Interventions: Drug: LY2599666;   Drug: Solanezumab;   Drug: Placebo SC;   Drug: Placebo IV
4 Recruiting Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)
Condition: Alzheimer's Disease
Interventions: Drug: Piromelatine;   Drug: Placebo
5 Recruiting SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
Condition: Alzheimer's Disease
Interventions: Drug: SUVN-502;   Drug: Placebo
6 Recruiting Long Term, Extension Study of the Safety and Efficacy of AVP-786 (Deuterated [d6] Dextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Condition: Agitation in Alzheimer's Disease
Intervention: Drug: AVP-786
7 Recruiting Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment
Condition: Breast Cancer
Intervention: Drug: FDG-PET, [18F]Flutemetamol
8 Recruiting Cognitive Training and Practice Effects in MCI
Condition: Mild Cognitive Impairment
Intervention: Behavioral: computerized cognitive exercises
9 Recruiting An Efficacy and Safety Study of LY3314814 in Early Alzheimer's Disease
Condition: Alzheimer´s Disease
Interventions: Drug: LY3314814;   Drug: Placebo
10 Recruiting A Study of LY3314814 in Participants With Mild Alzheimer's Disease Dementia
Condition: Alzheimer's Disease
Interventions: Drug: LY3314814;   Drug: Placebo
11 Recruiting Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study
Condition: Alzheimer's Disease
Interventions: Drug: RVT-101;   Drug: Placebo
12 Recruiting Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Azeliragon;   Drug: Placebo
13 Recruiting A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ABBV-8E12;   Drug: placebo for ABBV-8E12
14 Recruiting Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ALZT-OP1a;   Drug: ALZT-OP1b;   Other: Placebo ALZT-OP1a;   Other: Placebo ALZT-OP1b
15 Recruiting 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Aducanumab (BIIB037);   Drug: Placebo
16 Recruiting Efficacy, Safety and Tolerability of AVP-786 (Deuterated [d6]-Dextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Condition: Agitation in Patients With Dementia of the Alzheimer's Type
Interventions: Drug: AVP-786;   Drug: Placebo
17 Recruiting Efficacy, Safety, and Tolerability of AVP-786 (Deuterated [d6]-Dextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Condition: Agitation in Patients With Dementia of the Alzheimer's Type
Interventions: Drug: AVP-786;   Drug: Placebo
18 Recruiting CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Drug: Crenezumab;   Drug: Placebo
19 Recruiting A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD
Condition: Alzheimer Disease
Interventions: Biological: LY3002813;   Drug: Placebo
20 Recruiting A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)
Conditions: Alzheimer Disease;   Mild Cognitive Impairment
Intervention: Drug: Florbetapir F 18 PET Scan

   Previous Page Studies Shown (1-20) Next Page (21-21) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.